March 5 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said that its consolidated net profit grew by an annual 34% to 133.9 million denars ($2.4 million/2.2 million euro) in 2019, backed by higher revenue.
Replek's operating revenue rose 12% to 1.1 billion denars last year, the company said in an annual financial statement.
Domestic sales added 6% to 421.8 million denars, while sales abroad were 9% higher at 627.5 million denars. Other operating revenue soared to 63.9 million denars last year from 17.2 million denars in 2018.
The company's operating expenses increased 8% to 980 million denars, as personnel costs rose 9% to 289.8 million denars.
(1 euro = 61.78 denars)